Upstream Bio (UPB) Receivables - Net (2023 - 2026)

Upstream Bio (UPB) posted quarterly Receivables - Net of $1.0 million for Q1 2026, up 82.69% year-over-year from $566000.0 in Q1 2025, and up 54.79% quarter-over-quarter from $668000.0 in Q4 2025.

Upstream Bio (UPB) Receivables - Net (2023 - 2026) Analysis & Trends

Upstream Bio's Receivables - Net history runs 4 years deep, the most recent figure standing at $1.0 million for Q1 2026.

  • In Q1 2026, Receivables - Net rose 82.69% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (up 82.69% YoY), while the FY2025 annual figure was $668000.0, up 8.97% from the prior year.
  • Receivables - Net for Q1 2026 stood at $1.0 million, up from $668000.0 in the prior quarter.
  • The five-year high for Receivables - Net was $1.0 million in Q1 2026, with the low at $98000.0 in Q4 2023.
  • The 4-year median for Receivables - Net is $613000.0 (2024), against an average of $611777.8.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Net soared 525.51% in 2024, then climbed 8.97% in 2025.
  • Upstream Bio's Receivables - Net stood at $98000.0 in 2023, then jumped by 525.51% to $613000.0 in 2024, then climbed by 8.97% to $668000.0 in 2025, then soared by 54.79% to $1.0 million in 2026.
  • Business Quant data shows UPB's Receivables - Net at $1.0 million in Q1 2026, $668000.0 in Q4 2025, and $683000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Upstream Bio 387.23 Mn 387.23 Mn -3.29 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 772,000.00
Jun 30, 2026 772,000.00
Mar 31, 2026 1.03 Mn
Mar 31, 2026 1.03 Mn
Dec 31, 2025 668,000.00
Dec 31, 2025 668,000.00
Sep 30, 2025 683,000.00
Sep 30, 2025 683,000.00
Jun 30, 2025 937,000.00
Jun 30, 2025 937,000.00
Mar 31, 2025 566,000.00
Mar 31, 2025 566,000.00
Dec 31, 2024 613,000.00
Dec 31, 2024 613,000.00
Sep 30, 2024 607,000.00
Sep 30, 2024 607,000.00
Dec 31, 2023 98,000.00
Dec 31, 2023 98,000.00
Sep 30, 2023 300,000.00
Sep 30, 2023 300,000.00